February 26, 2017
Recommended Topic Related To:

Tribenzor

"Nov. 1, 2012 -- Having even mildly elevated blood pressure at midlife prematurely ages the brain, a new study shows.

Researchers say the early changes seen with higher blood pressure may set the stage for problems with thinking, memor"...

A A A

Tribenzor




Indications
Dosage
How Supplied

INDICATIONS

Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide) is indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with Tribenzor.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Limitations Of Use

This fixed combination drug is not indicated for the initial therapy of hypertension.

DOSAGE AND ADMINISTRATION

Dose once daily. Dosage may be increased in 2 week intervals, as needed. The maximum recommended dose of Tribenzor is 40/10/25 mg.

Dose selection should be individualized based on previous therapy.

HOW SUPPLIED

Dosage Forms And Strengths

Tribenzor tablets are available in the following strength combinations:

  20/5/12.5 40/5/12.5 40/5/25 40/10/12.5 40/10/25
Olmesartan medoxomil (mg) 20 40 40 40 40
Amlodipine equivalent (mg) 5 5 5 10 10
Hydrochlorothiazide (mg) 12.5 12.5 25 12.5 25

Storage And Handling

Tribenzor tablets contain olmesartan medoxomil, amlodipine besylate at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide in the strengths described below.

Tribenzor tablets are differentiated by tablet color/size and are debossed with an individual product tablet code on one side. Tribenzor tablets are supplied for oral administration in the following strength and package configurations:

Tablet Strength (OM/AML equivalent/HCTZ) Package Configuration NDC# Product Code Tablet Color
20 /5 /12.5 mg Bottle of 30
Bottle of 90
10 blisters of 10
65597-114-30
65597-114-90
65597-114-10
C51 Orange white
40 /5 /12.5 mg Bottle of 30
Bottle of 90
10 blisters of 10
65597-115-30
65597-115-90
65597-115-10
C53 Light yellow
40 /5 /25 mg Bottle of 30
Bottle of 90
10 blisters of 10
65597-116-30
65597-116-90
65597-116-10
C54 Light yellow
40 /10 /12.5 mg Bottle of 30
Bottle of 90
10 blisters of 10
65597-117-30
65597-117-90
65597-117-10
C55 Grayish red
40 /10 /25 mg Bottle of 30
Bottle of 90
10 blisters of 10
65597-118-30
65597-118-90
65597-118-10
C57 Grayish red

Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F) [see USP Controlled Room Temperature].

Manufactured for Daiichi Sankyo, Inc., Parsippany, New Jersey 07054. Manufactured by Daiichi Sankyo Europe GmbH, Germany. Revised: Jan 2017

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 1/30/2017

Indications
Dosage
How Supplied

Tribenzor - User Reviews

Tribenzor User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Tribenzor sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Hypertension

Get tips on handling your hypertension.